Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11123329rdf:typepubmed:Citationlld:pubmed
pubmed-article:11123329lifeskim:mentionsumls-concept:C0023270lld:lifeskim
pubmed-article:11123329lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:11123329lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:11123329lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:11123329lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:11123329lifeskim:mentionsumls-concept:C0599958lld:lifeskim
pubmed-article:11123329lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:11123329pubmed:issue1lld:pubmed
pubmed-article:11123329pubmed:dateCreated2001-1-3lld:pubmed
pubmed-article:11123329pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:abstractTextPersistent immunity against Leishmania: infections in humans is mediated predominantly by CD4(+) T cells of the Th1 phenotype. Herein we report the expression cloning of eight Leishmania: Ags using parasite-specific T cell lines derived from an immune donor. The Ags identified by this technique include the flagellar proteins alpha- and beta-tubulin, histone H2b, ribosomal protein S4, malate dehydrogenase, and elongation factor 2, as well as two novel parasite proteins. None of these proteins have been previously reported as T cell-stimulating Ags from Leishmania: beta-tubulin-specific T cell clones generated against Leishmania: major amastigotes responded to Leishmania:-infected macrophages and dendritic cells. IFN-gamma enzyme-linked immunospot analysis demonstrated the presence of T cells specific for several of these Ags in PBMC from self-healing cutaneous leishmaniasis patients infected with either Leishmania: tropica or L. major. The responses elicited by Leishmania: histone H2b were particularly striking in terms of frequency of histone-specific T cells in PBMC (1 T cell of 6000 PBMC) as well as the percentage of responding donors (86%, 6 of 7). Ags identified by T cells from immune donors might constitute potential vaccine candidates for leishmaniasis.lld:pubmed
pubmed-article:11123329pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:languageenglld:pubmed
pubmed-article:11123329pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11123329pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123329pubmed:statusMEDLINElld:pubmed
pubmed-article:11123329pubmed:monthJanlld:pubmed
pubmed-article:11123329pubmed:issn0022-1767lld:pubmed
pubmed-article:11123329pubmed:authorpubmed-author:ProbstPPlld:pubmed
pubmed-article:11123329pubmed:authorpubmed-author:GhalibH WHWlld:pubmed
pubmed-article:11123329pubmed:authorpubmed-author:ReedS GSGlld:pubmed
pubmed-article:11123329pubmed:authorpubmed-author:WebbJ RJRlld:pubmed
pubmed-article:11123329pubmed:authorpubmed-author:MozelMMlld:pubmed
pubmed-article:11123329pubmed:authorpubmed-author:BadaroRRlld:pubmed
pubmed-article:11123329pubmed:authorpubmed-author:StrombergEElld:pubmed
pubmed-article:11123329pubmed:issnTypePrintlld:pubmed
pubmed-article:11123329pubmed:day1lld:pubmed
pubmed-article:11123329pubmed:volume166lld:pubmed
pubmed-article:11123329pubmed:ownerNLMlld:pubmed
pubmed-article:11123329pubmed:authorsCompleteYlld:pubmed
pubmed-article:11123329pubmed:pagination498-505lld:pubmed
pubmed-article:11123329pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:meshHeadingpubmed-meshheading:11123329...lld:pubmed
pubmed-article:11123329pubmed:year2001lld:pubmed
pubmed-article:11123329pubmed:articleTitleIdentification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning.lld:pubmed
pubmed-article:11123329pubmed:affiliationCorixa Corporation, Seattle, WA 98104, USA. jwebb@uottawa.calld:pubmed
pubmed-article:11123329pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11123329pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11123329pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11123329lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11123329lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11123329lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11123329lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11123329lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11123329lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11123329lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11123329lld:pubmed